Ignite Creation Date:
2024-05-06 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05179876
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2021-12-17
Brief Title:
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
A Prospective Open-label Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent Studies
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PLATYPUS
Brief Summary:
The purpose of the study is to enable participants with pulmonary hypertension PH currently treated with study interventions in a clinical study parent studies NCT03422328 NCT03904693 and NCT04565990 to continue to benefit from the intervention after closure of the parent study in case they have no alternative means of access to the study intervention This study will allow assessment of the long-term safety of each study intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2021-002297-11 | EUDRACT_NUMBER | None | None |
| NOPRODPAPUH3001 | OTHER | Actelion | None |